Farhad Islami, MD, PhD

Surveillance and Health Services Research, American Cancer Society, Atlanta, USA

Farhad Islami is the Strategic Director of Cancer Surveillance Research at the American Cancer Society. He earned his MD from Tehran University of Medical Sciences, Iran, in 1994. He became involved in the design and conduct of several epidemiological research studies on cancer in Iran, including the Golestan Cohort Study, a prospective population-based study with over 50,000 participants. He continued his research at the International Agency for Research on Cancer, Lyon, France, from 2006 and obtained a PhD in Epidemiology from the King’s College London, United Kingdom. He moved to the Mount Sinai School of Medicine in New York in 2011, and then joined the American Cancer Society in 2014. His work focuses on investigating the associations between tobacco or other modifiable risk factors and cancer and evaluating the effects of interventions for cancer prevention, including tobacco control, in reducing cancer morbidity and mortality.